_in_the_Breast_Imaging_Market.JPG)
The Global Artificial Intelligence (AI) In the Breast Imaging Market Size is valued at 367.83 million in 2022 and is predicted to reach 3579.62 million by the year 2031 at a 28.9% CAGR during the forecast period for 2023-2031.
Breast imaging represents a branch of medicine where artificial intelligence (AI) has made major strides. AI technology helps to improve the precision and effectiveness of breast imaging methods, resulting in better patient outcomes and diagnosis. Several variables that support the development and acceptance of artificial intelligence (AI) in breast imaging influence the market dynamics in this area.
The performance and accuracy of AI models used in breast imaging have considerably increased thanks to developments in AI algorithms, notably deep learning and machine learning methods. The popularity of AI in this industry has increased as a result of the creation of complex AI algorithms that can analyze huge amounts of imaging data.
However, the availability and delivery of hardware and software components for AI systems have been impacted by the disruption of global supply chains caused by the COVID-19 epidemic. The use of AI solutions in breast imaging departments may have been hampered by delays in equipment installation and purchase.
Competitive Landscape:
Some of the major Artificial Intelligence (AI) in Breast Imaging Market players are:
- GE Healthcare
- Hologic, Inc.
- Gamma Medica, Inc.
- Siemens Healthcare
- Fujifilm Holdings Corp.
- Toshiba Corporation
- Aurora Imaging Technology, Inc.
Market Segmentation:
The Artificial Intelligence (AI) in Breast Imaging Market is segmented on the basis of end-use. Based on end-use, the market is segmented into hospitals, ambulatory surgical centers, and specialty clinics & trauma centers.
Based On End-Use, The Hospitals' Segment Is Accounted As A Major Contributor To Artificial Intelligence (AI) In Breast Imaging Market
The hospitals' category is expected to hold a major share in the global Artificial Intelligence (AI) in Breast Imaging Market in 2022. The rise of the artificial intelligence market for breast imaging is predicted to be positively impacted by rising healthcare IT spending. It is predicted that the increased spending will help to improve the digital infrastructure, which will hasten the use of AI in hospitals and other healthcare facilities. The length of hospital stays, total healthcare expenses, the grade of care, and the accessibility of emergency care are all positively impacted by a hospital's capacity to provide modern, well-equipped facilities. The increase in global spending on healthcare infrastructure will support market expansion in the coming years.
In The Region, The North America Artificial Intelligence (AI) In Breast Imaging Market Holds A Significant Revenue Share
The North America Artificial Intelligence (AI) in Breast Imaging Market is expected to register the highest market share in terms of revenue in the near future. The market for AI in breast imaging is dominated by North America. The high incidence of breast cancer, sophisticated healthcare infrastructure, robust research and development efforts, and rising investments in AI technologies are some of the variables that influence market size. Because AI is being used in more breast imaging applications, the market is predicted to expand further. The market for artificial intelligence in breast imaging in the Asia Pacific is projected to expand significantly.
The increased prevalence of breast cancer, major R&D investments in its therapies, and improvements in breast imaging technology are the primary drivers of the market's expansion.
Artificial Intelligence (AI) In the Breast Imaging Market Report Scope:
|
Report Attribute |
Specifications |
|
Market Size Value In 2022 |
USD 367.83 Mn |
|
Revenue Forecast In 2031 |
USD 3579.62 Mn |
|
Growth Rate CAGR |
CAGR of 28.9 % from 2023 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Bn and CAGR from 2023 to 2031 |
|
Historic Year |
2019 to 2022 |
|
Forecast Year |
2023-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
End-user |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; South East Asia |
|
Competitive Landscape |
GE Healthcare, Hologic, Inc., Gamma Medica, Inc., Siemens Healthcare, Fujifilm Holdings Corp., Toshiba Corporation, Aurora Imaging Technology, Inc. |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing and Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Corporate
Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
info@insightaceanalytic.com
